About PEPDOO®
Who We Are
PEPDOO® is the flagship brand of EYOSON Group, a national high-tech enterprise with over 15 years of expertise in functional peptide R&D and industrial application. We specialize in the large-scale production of bioactive peptides through cutting-edge scientific innovation, supported by a strong foundation in biotechnology and artificial intelligence.
Our core technology—OKPEP® Precision Peptide Platform—integrates AI-driven enzyme discovery with functional target recognition, enabling molecular-level peptide manufacturing that is both precise and scalable. With over 5000 global patents, participation in the drafting of multiple national peptide standards, and recognized breakthroughs in marine oligopeptide research, we are proud to lead the industry in both innovation and standardization.
PEPDOO® offers over 4,000 peptide-based product solutions, serving global markets in health supplements, special medical foods, sports nutrition, and cosmetic formulations. Our 40,000㎡ advanced production base and over 6,000 tons of annual output capacity ensure our ability to scale innovation for real-world impact.
Our Mission
At PEPDOO®, our mission is to elevate human health and well-being through science-backed bioactive peptides. We believe in precision, performance, and purpose—using advanced biotechnology and AI to deliver peptide solutions that are not only effective, but safe, traceable, and sustainable.
We are more than manufacturers—we are pioneers on a mission to redefine what’s possible in the peptide industry.
Our Core Technology: OKPEP®
At the heart of PEPDOO® lies OKPEP®, a proprietary peptide technology platform built on six pillars of precision: enzymatic specificity, sequence control, quantitative accuracy, target alignment, functional validation, and optimized absorption.
Using AI-powered enzyme selection and functional bio-screening, OKPEP® identifies bioactive amino acid sequences and executes precise enzymatic cutting—producing highly specific functional peptides with fast bioavailability and clear health benefits.
This next-generation platform serves as the molecular engine of our peptide innovation, delivering products that meet our gold-standard criteria: